Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of oxybutynin in urological practice.

Literature DB >> 3429165

The use of oxybutynin in urological practice.

Abstract

A total of 216 patients with voiding disorders were treated with oxybutynin and the effects and side effects were studied. The drug is effective in a wide variety of disorders. Good results were obtained in 66% of patients who had no previous treatment and in 46% of patients who had taken various drugs before. It was just as effective in all age groups. Twenty-three per cent of patients experienced side effects and 10% were unable to tolerate the drug. It is concluded that oxybutynin is an effective drug in the treatment of unstable bladder and disorders such as catheter-induced spasms.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1987 PMID： 3429165 DOI： 10.1007/BF02550355

Source DB: PubMed Journal: Int Urol Nephrol ISSN： 0301-1623 Impact factor: 2.370

16 in total

1. Oxybutynin chloride (Ditropan) in enuresis.

Authors: P J Buttarazzi
Journal: J Urol Date: 1977-07 Impact factor: 7.450

2. The role of adjunctive drug therapy for intermittent catheterization and self-catheterization in children with vesical dysfunction.

Authors: N Hilwa; A D Perlmutter
Journal: J Urol Date: 1978-04 Impact factor: 7.450

Review 4. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.

Authors: Y E Yarker; K L Goa; A Fitton
Journal: Drugs Aging Date: 1995-03 Impact factor: 3.923

4 in total

The use of oxybutynin in urological practice.

1. Oxybutynin chloride (Ditropan) in enuresis.

2. The role of adjunctive drug therapy for intermittent catheterization and self-catheterization in children with vesical dysfunction.

3. A study of the anticholinergic and antispasmodic activity of oxybutynin (Ditropan) on rabbit detrusor.

4. Oxybutynin in bladder spasm, neurogenic bladder, and enuresis.

5. Effect of oxybutynin chloride on bladder spasm following transurethral surgery.

6. Characterization of the oxybutynin antagonism of drug-induced spasms in detrusor.

7. Oxybutynin chloride in control of post-trasurethral vesical pain and spasm.

8. Oxybutynin Chloride (Ditrophan)--clinical uses and limitations.

9. A double-blind crossover trial of baclofen--a new treatment for the unstable bladder syndrome.

10. Comparative in vitro effects of imipramine, oxybutynin, and flavoxate on rabbit detrusor.

1. Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect data.

Review 2. Botulinum toxin treatment for overactive bladder and detrusor overactivity in adults.

3. Ondansetron versus diclofenac sodium in the treatment of acute ureteral colic: a double blind controlled trial.

Review 4. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.